A technique for long-term atrial pacing is described. It uses the system whereby power from an external pulse-generator (including battery) is transferred through the intact skin by inductivecoupling. Once installed, there is no requirementforfurther surgery to effect battery changes, and the patient can control his heart rate over a wide range to suit his needs.
A technique for long-term atrial pacing is described. It uses the system whereby power from an external pulse-generator (including battery) is transferred through the intact skin by inductivecoupling. Once installed, there is no requirementforfurther surgery to effect battery changes, and the patient can control his heart rate over a wide range to suit his needs.
It is suggested that pacing by such means may offer a preferable alternative to drug therapy in the treatment of low cardiac output due to pathological sinus bradycardia. Two patients successfully treated in this way are reported.
Sinus bradycardia may be a more common cause of disability than hitherto recognized (Shaw and Eraut, I970) . When pathological it is incapacitating because of the limitation it imposes on the cardiac output response to exercise and other stimuli; in very severe cases there may also be a liability to Adams-Stokes attacks. Where indicated, treatment has usually been by sympathomimetic or parasympatholytic drugs (Bellet, I963; Friedberg, i966) , but artificial pacemaking has occasionally been required (Shaw and Eraut, 1970) . In these cases the pacing stimuli have been applied to the right ventricle, with consequent loss of the atrial transport function and potential risk of pacemaker-induced ventricular tachydysrhythmia. We here describe an atrial pacing system which is free of these disadvantages and of the great drawback of most 'permanent' pacing systems in current use, namely the requirement for periodic operations to replace the unit. Our early experience suggests that long-term atrial pacing by this technique may be preferable to drug therapy where the latter produces unpleasant side-effects.
Equipment and technique
The Lucas inductive-coupling system (Abrams, Hudson, and Lightwood, I960; Taylor, I966; Clarke, Evans, and Milstein, I970) has been modified by the makers to provide braided stainless steel ring terminals to the output leads of the secondary coil (Fig. i) in front of the sino-atrial node, and a similar distance apart. Additional anchorage and haemostasis are provided by a covering patch of Teflon felt. The pericardium is loosely closed about the leads with 3 or 4 sutures, and the silicone-rubber covered secondary coil left in a subcutaneous pocket at the usual site (Fig. 2) . The wound is closed after ascertaining that an adequate pacing stimulus can be induced with the primary coil 4 cm. or more vertically above the secondary.
The external components of the system are standard, the pulse-generator being powered by the universally-obtainable U2 cell. Rate control is in the hands of the patient and a choice of power settings is available. At normal power setting and average rates, the battery life is usually 3 to 4 weeks and changes are quickly, easily, and safely effected by substituting the spare generator with attached primary coil. It is necessary to tape this coil to the skin in the desired position relative to the secondary coil; this is aesthetically unsatisfactory but in practice no great disadvantage.
Case reports
Case I A 62-year-old man was admitted to this unit in February I969. He had been dyspnoeic on moderate exertion for 5 years. Sinus bradycardia had been diagnosed and treated with longacting isoprenaline. This produced no sustained improvement and he had to give up his work as a postman. Latterly he had been dyspnoeic on walking a few yards on the flat. He had been orthopnoeic and liable to attacks of paroxysmal nocturnal dyspnoea in spite of the use of five pillows and treatment with diuretics.
He also suffered from Meniere's syndrome but gave no history of syncopal attacks.
Physical examination confirmed orthopnoea Clinical examination revealed no abnormality apart from a fixed heart rate of 40 a minute, with occasional irregularity, and right brachial blood pressure of I30/85 mm. Hg. The chest x-ray was normal.
The electrocardiogram showed sinus bradycardia occasionally interrupted by ventricular extrasystoles. Other investigations yielded no relevant findings.
Test infusions of isoprenaline and atropine both produced a satisfactory increase in heart rate, but she found the side-effects of the oral preparations intolerable. A permanent atrial pacing system was installed and was functioning normally (on 'lowpower' setting and usually about 7o a minute) at follow-up 7 months later. She had experienced no effort dyspnoea or dizziness and no angina since the operation; she volunteered the information that she could not remember ever having felt so alert before.
Pace-made electrocardiogram Fig. 3 shows the sequence of atrial stimulation by the pacemaker and ventricular activation after an appropriate PR interval in each case. As noted by Lister et al. (I965), this interval varies directly with heart rate (Fig. 4) and not inversely as in the physiological state or when heart rate is increased by atropine or isoprenaline. In Case I the PR interval increased from OI4 sec. at a frequency of 40 a minute to 024 sec. at Ioo a minute. In Case 2 the interval was o-i8 sec. at 6o a minute and 0-24 sec. at I35 a minute. Both patients have physiological PR intervals at their usual pace-made rates of 70-80 a minute, and at these rates the nodal and ventricular ectopic activity seen during bradycardia is not in evidence. They have not been tested for development of AV dissociation at very fast atrial rates.
Discussion
The sinus bradycardia shown by these two patients bore no relation to that of the trained athlete and none of the well-known pathological states associated with such bradycardia was found. Nor was there evidence of specific cardiac disease, though the second patient had angina pectoris when her pulse rate was slow. Selective coronary arteriography was not carried out.
These cases might be considered examples of the 'lazy sinus syndrome' (Shaw and Sowton, I965) , and avoidance of any risk of pacemaker-induced ventricular tachydysrhythmia (Siddons and Sowton, I967) . The risk of atrial dysrhythmia due to competitive sinus rhythm (Sowton, I965) must be small where the rate of the natural pacemaker is so slow. Above all, the fact that the pulse-generator is external and easily interchangeable guarantees safety, and there is no requirement for biennial or more frequent operations to change batteries as they fail.
Thoracotomy could be avoided by use of a transvenous system, but pacing by this means Sinus bradycardia treated by long-term atrial atrial pacing 461 has proved unreliable because of instability of the electrode tip (Kastor et al. I969) . Stable transvenous atrial pacing has been accomplished by placement of the electrode in the proximal portion of the coronary sinus, but this method is not recommended for routine use because of the potential hazards of perforation and thrombus formation (Moss, Rivers, and Cooper, i969) . It is concluded that, at present, the most reliable way to establish long-term atrial pacing is to suture the electrodes to the atrium.
